Prosecution Insights
Last updated: April 19, 2026

Arentfox Schiff, LLP & Memorial Sloan-Kettering

5 pending office actions • 4 clients

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Client Portfolio (4 clients)

Client (Assignee)Pending OAs
Memorial Sloan Kettering Cancer Center 2
Cornell University 1
The Curators of the University of Missouri 1
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18433538 METHODS OF CANCER TREATMENT VIA REGULATED FERROPTOSIS Cornell University WHEELER, THURMAN MICHAEL 1619 Non-Final OA Feb 06, 2024
17961761 NANOPARTICLE IMMUNOCONJUGATES The Curators of the University of Missouri HUYNH, PHUONG N 1641 Non-Final OA Oct 07, 2022
17909310 ANTI-CCR8 AGENTS Memorial Sloan Kettering Cancer Center SULLIVAN, DENNIS JOHN 1642 Non-Final OA Sep 02, 2022
17770259 HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPY Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. MIDDLETON, DANAYA L 1674 Final Rejection Apr 19, 2022
17536715 TUMOR MUTATIONAL LOAD Memorial Sloan Kettering Cancer Center MOSELEY II, NELSON B 1642 Final Rejection Nov 29, 2021

Managing Arentfox Schiff, LLP & Memorial Sloan-Kettering's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month